Table 1.

Frequency of various ASAbs in patients with IIM and associated clinical features; Huang, 2020 [12].

Antibody	Prevalence in Patients with Myositis	Myositis	Arthritis	ILD
Anti-Jo-1	15–30%	82%	74%	82%
Anti-Pl-7	2–5%	80%	50%	77%
Anti-PL-12	2–5%	51%	42%	83%
Anti-EJ	<2%	84%	53%	90%
Anti-OJ	<2%	78%	44%	61%
Anti-KS	<2%	-	-	-
Anti-Zo	<1%	-	-	-
Anti-Ha	<1%	-	-	-